Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Schneider National, Inc.
SNDR·Industrials
B ★★★Hold
Current$29.23
Target$30.00
Return+2.6%
Nov 1, 2026

Schneider offers a credible cyclical earnings recovery through stronger trucking margins and intermodal expansion, but elevated historical valuation multiples and capital-intensive operations constrain its margin of safety.

Score
67
Advanced Energy Industries, Inc.
AEIS·Industrials
B ★★★Hold
Current$222.06
Target$295.26
Return+33.0%
Nov 1, 2026

Advanced Energy benefits from rising semiconductor complexity and AI data-center power demand, with strong earnings recovery potential, but elevated investment spending, dilution, and uncertain cash conversion constrain the upside.

Score
67
Rocket Companies, Inc.
RKT·Financials
B ★★★Hold
Current$12.80
Target$14.20
Return+10.9%
Nov 1, 2026

Rocket's integrated mortgage and servicing ecosystem could deliver substantial earnings growth through recapture and efficiency gains, but mortgage cyclicality, acquisition leverage, and demanding normalized earnings expectations limit near-term upside.

Score
67
Merck & Co., Inc.
MRK·Healthcare
B ★★★Hold
Current$149.52
Target$155.04
Return+3.7%
Nov 1, 2026

Merck combines a powerful oncology franchise, substantial cash generation, and a promising drug pipeline, but its valuation and dependence on successfully replacing future KEYTRUDA revenue limit the current margin of safety.

Score
67
WEC Energy Group, Inc.
WEC·Utilities
B ★★★Hold
Current$116.07
Target$118.75
Return+2.3%
Nov 1, 2026

WEC Energy offers durable regulated utility earnings, growing electricity demand and reliable dividends, but heavy capital requirements, leverage and a demanding valuation constrain shareholder upside.

Score
67
Mirion Technologies, Inc.
MIR·Industrials
B ★★★Hold
Current$18.37
Target$20.10
Return+9.4%
Oct 31, 2026

Mirion benefits from long-term nuclear safety and radiation technology demand, supported by accelerating orders and cash generation, but acquisition-related dilution, leverage, and a demanding earnings multiple limit near-term upside.

Score
67
Indivior Pharmaceuticals, Inc.
INDV·Healthcare
B ★★★Hold
Current$35.37
Target$39.60
Return+12.0%
Oct 31, 2026

Indivior combines a profitable, growing addiction-treatment franchise with potential Supernus merger synergies, but weak cash conversion, new financing obligations, and integration uncertainty constrain its investment appeal.

Score
67
Floor & Decor Holdings, Inc.
FND·Consumer Discretionary
B ★★★Hold
Current$47.59
Target$51.70
Return+8.6%
Oct 31, 2026

Floor & Decor can compound through specialty flooring market-share gains, national store expansion, and professional customer growth, but weak renovation demand and capital-intensive expansion constrain near-term returns.

Score
67
Smurfit Westrock Plc
SW·Materials
B ★★★Hold
Current$43.09
Target$50.82
Return+17.9%
Oct 31, 2026

Smurfit Westrock offers global packaging scale, dividend income, and earnings-recovery potential through pricing and integration gains, but weak capital returns, leverage, and volatile input costs constrain its valuation upside.

Score
67
Cenovus Energy Inc.
CVE·Energy
B ★★★Hold
Current$32.73
Target$35.03
Return+7.0%
Oct 31, 2026

Cenovus offers strong oil sands cash generation, operational scale, and acquisition-led production growth, but its elevated historical valuation and exposure to crude prices and integration risks limit near-term upside.

Score
67
UBS Group AG
UBS·Financials
B ★★★Hold
Current$47.69
Target$51.60
Return+8.2%
Oct 31, 2026

UBS can compound earnings through global wealth-management growth and Credit Suisse integration savings, but demanding book-value multiples and potentially higher Swiss capital requirements constrain shareholder upside.

Score
67